Evidence map›Paper›PMID 27701461›Full record

ArticlePloS one2016

MUC18 Regulates Lung Rhinovirus Infection and Inflammation.

Reena Berman, Di Jiang, Qun Wu, Connor R Stevenson, Niccolette R Schaefer, Hong Wei Chu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. CD146: a promising target in respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  2. Involvement of CD146 in theInfection and immunity · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Fine Particulate Matter (PMFrontiers in microbiology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Reena BermanDepartment of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, United States of America.
Di JiangDepartment of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, United States of America.
Qun WuDepartment of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, United States of America.
Connor R StevensonDepartment of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, United States of America.
Niccolette R SchaeferDepartment of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, United States of America.
Hong Wei ChuDepartment of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, United States of America.
University of Colorado Denver · USNational Jewish Health · US

Funding

IRAK-M in lung defense against rhinovirus infectionR01AI106287 · NIAID · NATIONAL JEWISH HEALTH · PI CHU, HONG W, LI, LIWU · 2014 to 2018
$2.0M
SPLUNC1 in Severe AsthmaR01HL125128 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHU, HONG W, DI, YUANPU PETER · 2015 to 2018
$1.9M
Novel function of MUC18: amplification of inflammation in allergic lungsR01HL122321 · NHLBI · NATIONAL JEWISH HEALTH · PI CHU, HONG W · 2015 to 2018
$1.6M
NHLBI NIH HHS R01 HL122321NHLBI NIH HHS R01 HL125128NIAID NIH HHS R01 AI106287
6 · The paper itself

Abstract

backgroundMUC18 is upregulated in the lungs of asthma and COPD patients. It has been shown to have pro-inflammatory functions in cultured human airway epithelial cells during viral infections and in mice during lung bacterial infections. However, the in vivo role of MUC18 in the context of viral infections remains poorly understood. The goal of this study is to define the in vivo function of MUC18 during respiratory rhinovirus infection.

methodsMuc18 wild-type (WT) and knockout (KO) mice were infected with human rhinovirus 1B (HRV-1B) and sacrificed after 1 day to determine the inflammatory and antiviral responses. To examine the direct effects of Muc18 on viral infection, tracheal epithelial cells isolated from WT and KO mice were grown under air-liquid interface and infected with HRV-1B. Finally, siRNA mediated knockdown of MUC18 was performed in human airway epithelial cells (AECs) to define the impact of MUC18 on human airway response to HRV-1B.

resultsBoth viral load and neutrophilic inflammation were significantly decreased in Muc18 KO mice compared to WT mice. In the in vitro setting, viral load was significantly lower and antiviral gene expression was higher in airway epithelial cells of Muc18 KO mice than the WT mice. Furthermore, in MUC18 knockdown human AECs, viral load was decreased and antiviral gene expression was increased compared to controls.

conclusionsOur study is the first to demonstrate MUC18's pro-inflammatory and pro-viral function in an in vivo mouse model of rhinovirus infection.

Indexed as

AnimalsCD146 AntigenCells, CulturedDisease Models, AnimalEpithelial CellsGene Expression RegulationHumansMiceMice, KnockoutPicornaviridae InfectionsRhinovirusTracheaViral LoadCD146 AntigenMCAM protein, humanMcam protein, mouse

Identifiers

PMID27701461
PMCPMC5049769
OpenAlexW2528297735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.